Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)
暂无分享,去创建一个
D. Scarlata | P. Audhya | J. Hertel | Harold R Locay | Lynnae S Jackson | R. Prathikanti | Lynnae Jackson